2Q2-23761-72505
3 vaccinations
8 coded responses
11 check-ins
8 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 481 / MI
- Registered
- 2021-12-04
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-17
Dose 1 — Pfizer-BioNTech
-
2021-05-06
Dose 2 — Pfizer-BioNTech
-
2021-12-02
Dose 3 — Moderna
-
2021-12-04
Registered in v-safe
-
2021-12-05
Survey response — days 1–6 daily, dose 3MedDRA: Swelling of eyelid — Feeling: Poor · Fatigue or tiredness, Rash, not including the immediate area around the injection siteFree text: Swollen eyelid for the past 3 daysMedDRA releases: 2024-11 · check-in free text available
-
2021-12-06
Survey response — days 1–6 daily, dose 3MedDRA: Rash, Swelling of eyelid, Urticaria — Feeling: Poor · Site: Pain · Headache, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesFree text: Swollen eyelid that appeared on Friday, 24 hours after receiving booster and at same time as rash and hives on my handsMedDRA releases: 2024-11 · check-in free text available
-
2021-12-07
Survey response — days 1–6 daily, dose 3MedDRA: Swelling of eyelid — Feeling: Fair · Fatigue or tiredness, Rash, not including the immediate area around the injection siteFree text: Swollen eyelidMedDRA releases: 2024-11 · check-in free text available
-
2021-12-08
Survey response — days 1–6 daily, dose 3MedDRA: Swelling of eyelid — Feeling: Good · Fatigue or tiredness, Rash, not including the immediate area around the injection siteFree text: Eyelid swellingMedDRA releases: 2024-11 · check-in free text available
-
2021-12-09
Survey response — day 7, dose 3MedDRA: Swelling of eyelid — Feeling: Fair · Fatigue or tiredness, Rash, not including the immediate area around the injection siteFree text: Eyelid swellingMedDRA releases: 2024-11 · check-in free text available
-
2021-12-17
Survey response — day 14, dose 3MedDRA: Dysmenorrhoea, Menstrual disorder, Menstrual headache, Nausea — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: My menstrual cycle started and the symptoms are significantly elevated compared to normal. Very sick to my stomach, nausea, body aches, cramps, headache for days leading up to, beyond what is typicalMedDRA releases: 2024-11 · check-in free text available
- 2021-12-25
-
2022-01-08
Survey response — day 35, dose 3MedDRA: Swelling of eyelid, Urticaria — Feeling: GoodFree text: Swollen eyelid, hives returned 10 days agoMedDRA releases: 2024-11 · check-in free text available
-
2022-01-13
Survey response — day 42, dose 3MedDRA: Cough, Exposure to SARS-CoV-2, Headache, Nausea, Oropharyngeal pain, SARS-CoV-2 test — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Headache for multiple days, nauseous, sore throat, dry cough. Exposed to Covid on Thursday, awaiting results of PCRMedDRA releases: 2024-11 · check-in free text available
-
2022-01-13
Report sent to call center — day 42, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-01-18
- 2022-03-05
- 2022-12-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-17 | Pfizer-BioNTech | No |
| 2 | 2021-05-06 | Pfizer-BioNTech | No |
| 3 | 2021-12-02 | Moderna | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Swollen eyelid for the past 3 days
Systemic reaction (other): Swollen eyelid that appeared on Friday, 24 hours after receiving booster and at same time as rash and hives on my hands
Systemic reaction (other): Swollen eyelid
Systemic reaction (other): Eyelid swelling
Release 10 — day 7, dose 3
Systemic reaction (other): Eyelid swelling
Release 10 — day 14, dose 3
Symptoms: My menstrual cycle started and the symptoms are significantly elevated compared to normal. Very sick to my stomach, nausea, body aches, cramps, headache for days leading up to, beyond what is typical
Release 10 — day 35, dose 3
Symptoms: Swollen eyelid, hives returned 10 days ago
Release 10 — day 42, dose 3
Symptoms: Headache for multiple days, nauseous, sore throat, dry cough. Exposed to Covid on Thursday, awaiting results of PCR
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Dysmenorrhoea | · | · | ✓ |
| SD | Exposure to SARS-CoV-2 | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Menstrual disorder | · | · | ✓ |
| SD | Menstrual headache | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | SARS-CoV-2 test | · | · | ✓ |
| SD | Swelling of eyelid | · | · | ✓ |
| SD | Urticaria | · | · | ✓ |
| SRO | Rash | · | · | ✓ |
| SRO | Swelling of eyelid | · | · | ✓ |
| SRO | Urticaria | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release